Literature DB >> 25299292

Do all neuropathy patients need an EMG at least once?

A Gordon Smith.   

Abstract

EMG, which consists of nerve conduction studies and needle electromyography, is an essential diagnostic tool in the evaluation of patients with suspected peripheral neuropathy. Many neurologists order an EMG for all patients with suspected peripheral neuropathy. Not surprisingly, evidence now exists that shows EMG is a major driver of health care costs associated with neuropathy diagnoses. As neurologic practice evolves from fee for service to value-based compensation, neurologists will need to justify the diagnostic utility of EMG (outcome) relative to its cost. While carefully performed studies of diagnostic utility in many patient populations are lacking, a robust literature provides guidance regarding the potential role and limitations of EMG in neuropathy diagnosis as well as the pitfalls referring providers and electrodiagnostic consultants must consider. Do all neuropathy patients need an EMG at least once? This article attempts to answer this question using an illustrative case to highlight critical factors every neurologist must consider before ordering an EMG for neuropathy diagnosis.

Entities:  

Mesh:

Year:  2014        PMID: 25299292     DOI: 10.1212/01.CON.0000455870.45685.c7

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  3 in total

1.  Sural Radial Amplitude Ratio: A Study in Healthy Indian Subjects.

Authors:  Khushnuma Mansukhani; Mayura Dhonde; Aarthika Sreenivasan; Alika Sharma; Lajita Balakrishnan; Priyanka Chavan
Journal:  Ann Indian Acad Neurol       Date:  2020-06-05       Impact factor: 1.383

2.  The provision of written information and its effect on levels of pain and anxiety during electrodiagnostic studies: A randomised controlled trial.

Authors:  Yan Ling Lai; Annemarie Van Heuven; Adeniyi Borire; Tejaswi Kandula; James G Colebatch; Arun V Krishnan; William Huynh
Journal:  PLoS One       Date:  2018-05-14       Impact factor: 3.240

3.  Validity and reliability of the Turkish version of the Michigan Neuropathy Screening Instrument

Authors:  Duygu Aktar Reyhanioğlu; Süleyman Cem Adiyaman; Murat Bektaş; Onur Bulut; Başak Özgen Saydam; Firat Bayraktar; Bilge Kara
Journal:  Turk J Med Sci       Date:  2020-06-23       Impact factor: 0.973

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.